Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004907375 | SCV005572653 | uncertain significance | not specified | 2024-07-30 | criteria provided, single submitter | clinical testing | The c.5063G>A (p.G1688E) alteration is located in exon 31 (coding exon 31) of the ABCA2 gene. This alteration results from a G to A substitution at nucleotide position 5063, causing the glycine (G) at amino acid position 1688 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |